OpenVSafe by OpenVAERS
Search V-safe

R88-33834-69590

2 vaccinations 2 coded responses 14 check-ins 0 free-text entries 2 call cases
Sex
Male
Age at first dose
0-4
ZIP prefix
598 / MT
Registered
2022-12-08
Relationship
Child or adolescent in my care
Guardian
ATY-28067-70476
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2022-11-10
    Dose 1 — Pfizer-BioNTech
    Co-administered: Flu
  2. 2022-12-08
    Registered in v-safe
  3. 2022-12-08
    Dose 2 — Pfizer-BioNTech
    Co-administered: Flu
  4. 2022-12-09
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Good · Site: Pain, Redness · Irritability/crying
    Under 3 check-in
  5. 2022-12-10
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Good · None
    Under 3 check-in
  6. 2022-12-11
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Good · None
    Under 3 check-in
  7. 2022-12-12
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Fair · Irritability/crying
    Under 3 check-in
  8. 2022-12-13
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Fair · Sleepiness, Rash, not including the immediate area around the injection site
    Under 3 check-in
  9. 2022-12-14
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Fair · Sleepiness, Rash, not including the immediate area around the injection site
    Under 3 check-in
  10. 2022-12-15
    Health check-in — day 7, dose 2, under 3
    Feeling: Fair · Sleepiness, Irritability/crying, Rash, not including the immediate area around the injection site
    Under 3 check-in
  11. 2022-12-22
    Health check-in — day 14, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  12. 2022-12-29
    Health check-in — day 21, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  13. 2023-01-05
    Survey response — day 28, dose 2, under 3
    MedDRA: Eczema, Pre-existing disease — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    MedDRA releases: 2024-11
  14. 2023-01-05
    Report sent to call center — day 28, dose 2, under 3
    Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  15. 2023-01-06
  16. 2023-01-14
    Health check-in — day 35, dose 2, under 3
    Feeling: Fair
    Under 3 check-in
  17. 2023-01-19
    Health check-in — day 42, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  18. 2023-03-10
    Health check-in — 3 months, dose 2, under 3
    Feeling: Fair
    Under 3 check-in
  19. 2023-06-10
    Survey response — 6 months, dose 2, under 3
    MedDRA: Rash vesicular — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    MedDRA releases: 2024-11
  20. 2023-06-10
  21. 2023-06-12
  22. 2023-06-12

Vaccinations

DoseDateManufacturerCo-administered
12022-11-10Pfizer-BioNTech Flu
22022-12-08Pfizer-BioNTech Flu

Call center

2 call center cases

2 unsuccessful

See the call center timeline

Free text

None.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDEczema · · ✓
SDPre-existing disease · · ✓
SDRash vesicular · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…